Dianthus Therapeutics, Inc. (DNTH) Free cash flow 2016–2022
Dianthus Therapeutics, Inc. (DNTH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.4MFY2022 · since FY2016: -$6.7M → -$29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$29.4M | -163.1% |
| FY2021 | -$11.2M | +82.7% |
| FY2020 | -$64.4M | -7.1% |
| FY2019 | -$60.2M | -21.4% |
| FY2018 | -$49.6M | -102.6% |
| FY2017 | -$24.5M | -266.9% |
| FY2016 | -$6.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice